Reply to correspondence on "Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis"

Clin Mol Hepatol. 2024 Oct;30(4):1039-1041. doi: 10.3350/cmh.2024.0801. Epub 2024 Sep 24.

Tian-Yi Ren¹, Mohammed Eslam², Jian-Gao Fan^{1

3}

¹ Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia.
³ Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China.

No abstract available

Keywords: Glucagon-like peptide-1 receptor agonist; Metabolic dysfunction-associated steatotic liver disease; Thiazolidinediones.